UBC’s contributions to combatting COVID-19
By dcc2012 | April 11, 2023
Look back at some of the UBC Faculty of Medicine’s efforts that contributed to our ongoing pandemic response and recovery.
Launching Canada’s Immuno-Engineering and Biomanufacturing Hub
By dcc2012 | March 27, 2023
Leaders from across B.C.’s biotech sector gathered to launch a new national research hub led by UBC.
From COVID-19 to the common cold: UBC scientists identify broadly-effective, infection-halting compound
By dcc2012 | December 14, 2022
The findings reveal a potential path toward antiviral treatments that could be used against multiple types of coronaviruses.
Strengthening pathogen research in British Columbia
By Qian Chow | November 18, 2022
New federal funding supports UBC researchers studying infectious diseases at the BCCDC Public Health Laboratory.
Bivalent vaccines are here – what it means for people who are pregnant
By Qian Chow | November 7, 2022
Dr. Deborah Money answers common questions that expecting parents have about vaccinations this fall.
UBC faculty of medicine researchers receive federal support to advance mRNA vaccine technologies
By Qian Chow | October 5, 2022
$11.1 million will improve the delivery and efficacy of mRNA vaccines and boost B.C. biotechnology impact on the global stage.
COVID-19 lockdown may have accelerated HIV transmission in some at-risk populations
By Qian Chow | September 23, 2022
A new UBC study sheds light on how COVID-19 pandemic restrictions impacted another public health threat — HIV.
Mobilizing vaccine research in a pandemic
By dcc2012 | August 26, 2022
When the pandemic hit, the Vaccine Evaluation Center worked at an unprecedented pace to enroll over 1.8 million participants in a study on the safety of COVID-19 vaccines.
COVID-19 and back-to-school
By dcc2012 | August 22, 2022
Children are entering a fourth school year in a pandemic. Pediatrics professor Dr. Manish Sadarangani shares expert advice for parents.
UBC researchers discover ‘weak spot’ across major COVID-19 variants
By dcc2012 | August 18, 2022
The findings pave the way for new antibody treatments that could be universally effective across variants.